The researchers grafted breast or
lung tumors in mice, allowed the tumors to grow to small size and removed these tumors surgically — essentially mimicking the situation in a human tumor patient in which the tumor is surgically removed as soon as possible after diagnosis.
Another replication attempt supported a 2011 Science Translational Medicine report from Stanford computational biologist Atul Butte's lab that the ulcer drug Tagamet slows the growth of
lung tumors in mice.
Now, in a new study in the journal Cancer Cell, Shaw and a team of scientists at the Salk Institute for Biological Studies found that phenformin, a derivative of the widely - used diabetes drug metformin, decreased the size of
lung tumors in mice and increased the animals» survival.
First, they induced
lung tumors in the mice by giving the mice chemicals.
Not exact matches
«Indeed,
in a second
tumor model of metastatic breast cancer, we demonstrated that
mice treated with the EphA2 - targeting paclitaxel conjugate presented nearly no
lung metastases, while a large numbers of lesions were observed
in both untreated
mice and
in mice treated with just paclitaxel.»
In the Cell study, Dr. Massagué, with Fellow Manuel Valiente, PhD, and other team members, found that in mouse models of breast and lung cancer — two tumor types that often spread to the brain — many cancer cells that enter the brain are killed by astrocyte
In the Cell study, Dr. Massagué, with Fellow Manuel Valiente, PhD, and other team members, found that
in mouse models of breast and lung cancer — two tumor types that often spread to the brain — many cancer cells that enter the brain are killed by astrocyte
in mouse models of breast and
lung cancer — two
tumor types that often spread to the brain — many cancer cells that enter the brain are killed by astrocytes.
Now,
in a provocative study that raises unsettling questions about the widespread use of vitamin supplements, Swedish researchers have showed that relatively low doses of antioxidants spur the growth of early
lung tumors in cancer - prone
mice, perhaps by hindering a well - known
tumor suppressor gene.
Compared to a control (left), epalrestat treatment (right) reduces the number of metastatic
tumors (arrowheads)
in the
lungs of
mice injected with human basal - like breast cancer cells.
Loss of either GSTO1 or RYR1, the researchers report, decreased the number of cancer stem cells
in the primary
tumor, blocked metastasis of cancer cells from the primary
tumor to the
lungs, decreased the duration of chemotherapy required to induce remission and increased the duration of time after chemotherapy was stopped that the
mice remained
tumor - free.
The MRI imaging detected metastatic
tumors, including micrometastases,
in lung, liver, lymph node, adrenal gland, bone, and brains of the
mice.
By blocking these
in lung endothelial cells, the researchers were able to slow
lung tumor growth
in mice and also reduce the spread of metastatic
tumors.
To clarify their role, the Cold Spring group allowed breast
tumors implanted
in mice to form micro-metastases
in the
lungs.
By using molecular genetic tools to reduce the amount of PC
in human
lung cancer cells, the team observed decreased cell growth, a compromised ability to form colonies
in soft agar (a gelatinous material specifically used to grow bacteria and other cells), and a reduced rate of
tumor growth
in mice.
By contrast, 16 out of 17
mice that produced annexin A2
in their cells developed metastatic
tumors in the liver,
lungs or abdominal cavity.
«We found that many more
mice developed
tumors when given the cells that we had engineered to have these stem cell characteristics, and they had a much higher incidence of metastasis
in the
lungs,» Kilian said.
Both the number and activity of osteoblasts — cells that produce and reshape bone tissue — were increased within the bone marrow of
mice with
lung tumors compared with cancer - free animals; and reducing the number of osteoblasts
in mice not only limited neutrophil infiltration of
tumors but also interrupted
tumor progression.
The cells exhibited many functions associated with
tumor progression; their presence within
mouse tumors substantially accelerated cancer growth, and
in human
lung tumors, a SiglecFhigh neutrophil signature was associated with poor patient survival.
«For example,
mouse mammary
tumors shared a signaling pathway that is found
in human
lung cancer and controls how cells reproduce and move from one location to another.»
The study builds on recent work by Tyler Jacks, the director of the Koch Institute, who has also used CRISPR to generate
lung and liver
tumors in mice.
The findings are significant, because the nanoparticles not only remained
in circulation, but also accumulated
in mouse tumors, as well as
in the
lungs of healthy
mice, suggesting that the approach also may enhance treatment for
lung diseases.
2) The two repeated experiments analyze the source of POSTN expression
in the
lung and whether it affects the number / size of primary and secondary
tumor formation
in a spontaneous
mouse model of breast cancer (MMTV - PyMT).
Salk scientists found that the diabetes drug phenformin was effective at reducing
tumor size
in mice with
lung cancer.
In the study, the researchers tested phenformin as a chemotherapy agent in genetically - engineered mice lacking LKB1 and which had advanced stage lung tumor
In the study, the researchers tested phenformin as a chemotherapy agent
in genetically - engineered mice lacking LKB1 and which had advanced stage lung tumor
in genetically - engineered
mice lacking LKB1 and which had advanced stage
lung tumors.
Five to six weeks after the resection of primary
tumors from
tumor - bearing NOD / SCID
mice,
lungs were harvested and fixed
in the Bouin's fixative solution overnight.
When they blocked IKK2 activity
in the
mice with
lung cancer, the
mice had smaller
tumors and lived longer, suggesting that the enzyme is necessary for NF - KB to stimulate
tumor growth.
The researchers now have plans to conduct further work to explore the safety and effectiveness of the approach
in vivo and
in advanced
lung tumor mouse models.
Further,
tumor to
lung volume ratio was substantially lower
in mice without Notch1 function; this ratio was 6 % at 6 weeks, 17 % at 18 weeks, and 20 % at 24 weeks
in normal
mice, and 4 %, 11 %, and 9.5 %, respectively,
in the Notch1 - knockdown
mice.
22) Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faça VM, Kelly - Spratt K, Wong CH, Zhang Q, Chin A, Park KS, Goodman G, Gazdar AF, Sage J, Dinulescu DM, Kucherlapati R, DePinho RA, Kemp CJ, Varmus HE, Hanash SM (2011)
Lung cancer signatures
in plasma based on proteome profiling of
mouse tumor models.
In this study, human
lung cancer cells with additional copies of the opioid receptor grew more than twice as fast as
tumor cells that lacked extra receptors when transplanted into
mice.
The media has given an astounding amount of attention to a recent study that found vitamin E may increase
tumor progression, and accelerate
lung cancer,
in mice.1
Ellagic acid is an effective inhibitor of
lung and esophageal
tumors in mice (Stoner).
«
Lung tumors in strain A
mice: application for studies
in cancer chemoprevention.»
In one other study, pomegranate juice extract given to
mice slowed down the growth of
lung tumors.
Administers veterinary staff approved supportive care such as dietary additives, supplemental environmental enrichment for hiding and chewing, heating pads, and subcutaneous fluids to distressed
mice and rats
in studies perusing new treatments for brain
tumors, Parkinson's disease, heart disease, and emphysema and genetic studies charting the development of
lung cancer and diabetes.